OncoPharm cover image

Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib

OncoPharm

00:00

Adjuvant Chemotherapy Context and Outcomes

John emphasizes benefit seen only in patients who received adjuvant chemo and discusses implications for micro-metastatic disease.

Play episode from 03:52
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app